Fifteen general practitioners conducted a randomized, double-blind comparative trial of two cerumenolytics, namely, Otocerol and Cerumol. A total of 106 patients were entered into the study (fifty-three in each group). Otocerol was shown to be marginally better than Cerumol in all parameters evaluated.
In a pilot study in general practice, using a double blind cross-over technique, twenty-six patients with menorrhagia were treated with Dicynene (ethamsylate) or a placebo preparation during four menstrual periods, each preparation being given for two consecutive periods.The number of tampons used and number of days of menstrual loss were recorded together with the patient's assessment of the severity of bleeding.On statistical analysis the results demonstrated the superiority of Dicynene over placebo in reducing the amount and duration of bleeding in menorrhagia.Twenty-five patients reported an absence of side-effects during the trial. Slight indigestion was recorded in one patient during Dicynene treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.